SCOPUS 정보 검색 플랫폼

Volumn 46, Issue 3, 2002, Pages 934-935

In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones [2]

(6) Schmitz, Franz Josef a Boos, Mechthild a Mayer, Susanne a Körer, Karl a Scheuring, Sibylle a Fluit, Ad C a

a UNIVERSITY HOSPITAL DÜSSELDORF (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GARENOXACIN; GATIFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; BACTERIUM ISOLATE; BACTERIUM MUTANT; IN VITRO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-INFECTIVE AGENTS; DNA TOPOISOMERASE IV; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; INDOLES; MICROBIAL SENSITIVITY TESTS; QUINOLONES; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0036168052 PISSN: 00664804 EISSN: None Source Type: Journal
DOI: 10.1128/AAC.46.3.934-935.2002 Document Type: Letter

Times cited : (11)

References (8)

1
- 0035112381
- In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus
- (2001) Antimicrob. Agents Chemother. , vol.45 , pp. 938-942
- Boos, M.¹ Mayer, S.² Fischer, A.³ Köhrer, K.⁴ Scheuring, S.⁵ Heisig, P.⁶ Verhoef, J.⁷ Fluit, A.C.⁸ Schmitz, F.-J.⁹

2
- 0033977308
- Antipneumococcal activities of gemifloxacin compared to those of nine other agents
- (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 304-310
- Davies, T.A.¹ Kelly, L.M.² Pankuch, G.A.³ Credito, K.L.⁴ Jacobs, M.R.⁵ Appelbaum, P.C.⁶

3
- 0034426122
- Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756
- (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 3351-3356
- Fung-Tome, J.C.¹ Minassian, B.² Kolek, B.³ Huezko, E.⁴ Aleksunes, L.⁵ Stickle, T.⁶ Washo, T.⁷ Gradelski, E.⁸ Valera, L.⁹ Bonner, D.P.¹⁰

4
- 0033964495
- Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different quinolones and originating from worldwide surveillance studies during the 1997-1998 respiratory season
- (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 462-466
- Jones, M.E.¹ Sahm, D.F.² Martin, N.³ Scheuring, S.⁴ Heisig, P.⁵ Thornsberry, C.⁶ Köhrer, K.⁷ Schmitz, F.-J.⁸

5
- 0003452701
- NCCLS document M100-M1S8. National Committee for Clinical Laboratory Standards, Villanova, Pa.
- (1998) Performance standards for antimicrobial susceptibility testing: Eighth informational supplement

6
- 0031979494
- Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC
- (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 1249-1252
- Schmitz, F.-J.¹ Jones, M.-E.² Hofmann, B.³ Hansen, B.⁴ Scheuring, S.⁵ Lückefahr, M.⁶ Fluit, A.⁷ Verhoef, J.⁸ Hadding, U.⁹ Heinz, H.-P.¹⁰ Köhrer, K.¹¹

7
- 0032937732
- In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone
- (1999) Antimicrob. Agents Chemother. , vol.43 , pp. 1077-1083
- Takahata, M.¹ Mitsuyama, J.² Yamashiro, Y.³ Yonezawa, M.⁴ Araki, H.⁵ Todo, Y.⁶ Minami, S.⁷ Watanabe, Y.⁸ Narita, H.⁹

8
- 0033753212
- Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: Identification of gyrA and parC and specification of point mutations associated with resistance
- (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 3196-3198
- Yan, S.S.¹ Fox, M.L.² Holland, S.M.³ Stock, F.⁴ Gill, V.J.⁵ Fedorko, D.P.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.